Luckbox Leans in with Mark Cuban
By James Melton
Cost Plus Drugs Company is selling prescription medications at dramatically low prices
What would happen if drug pricing made sense to consumers?
Mark Cuban Cost Plus Drug Company, which launched its online pharmacy about a year ago, is trying to answer that question. Its approach is easy to understand—even if it’s difficult to implement.
First, CPD negotiates directly with manufacturers to get the best possible price. It adds a 15% markup based on the per-pill price that CPD pays to buy the medicines. Then, CPD adds a flat $3 pharmacy labor fee and $5 standard shipping to get to the total retail price.
Cuban believes strongly in CPD’s mission and business model. Among his many ventures, this is the first company to...
Topics
-
ChatGPT Faces Competition as Bots Navigate Copyrights
|Meanwhile, high-quality data is costly and getting scarce, which impedes advances in generative AI -
Vertiv Pushed Back on A Recent Luckbox Story. Here is Our Response.
By Luckbox
|Vertiv’s points are well taken, however, they don’t ultimately change the overall analysis and outlook of the analysis. -
Databricks IPO: An AI Heavyweight with Nvidia’s Seal of Approval
|Data has been likened to gold in the new era of generative AI, which is one reason a potential Databricks IPO is so highly anticipated on Wall Street. -
Strong Economic Data Pushes Expected Rate Cut to Q3
|The bond rally might have to wait until late in the year -
Trump Media Part 2: How Traders Can Approach this Meme Stock
|Here is what to consider when evaluating the value of Trump Media & Technology Group -
Trump Media, Part 1: Risk Abounds in This Highly Volatile Listing
|Shares in the Trump Media & Technology Group appear to be setting up for a potential binary move in the wake of the 2024 presidential election -
Ford vs. General Motors
|Two venerable automakers face political and economic hassles. Are they good investments? -
It’s Not Easy Being Green
|Lawyers, lobbyists, legislators and lizards impede America’s transition to electric vehicles -
Less Than Electrifying
By Ed McKinley
|Range worries and sticker shock are slowing the growth of EV sales -
Retro Cool
By James Melton
|An upstart EV recalls a James Bond-like design equipped with a voice- activated cockpit -
Range Worry and Other EV Anxieties
By Ed McKinley
|An automotive journalist addresses the electric-vehicle market -
Adoption Issues
By James Melton
|Two experts assess EV appeal, environmental impact, jobs, and prices -
Fast-Charging Toyota
By James Melton
|The Japanese auto giant plans to jumpstart battery technology -
The Twelve Hottest New Cars of 2024
By James Melton
|From the practical to the aspirational, these new gas, hybrid and electric vehicles scorched their way to our shortlist -
Vertiv Holdings (VRT): A Q1 Earnings Beat is Paramount
|Vertiv Holdings (VRT) looks well-positioned to capitalize on the emerging AI revolution. But after a subpar Q4 2023 earnings report, the company still has a lot to prove heading into… -
Why Q1 Earnings Season is So Important for the Regional Banks
|The continued slide in shares of New York Community Bancorp (NYCB) shows the regional banking crisis isn’t yet resolved -
Synopsys (SNPS)-ANSYS (ANSS) Merger: Two Key Partners of Nvidia Unite
|Nvidia announced at its annual GPU Technology Conference (GTC) that it is expanding its partnership with ANSYS (ANSS) -
Inevitable Evolution
By Ed McKinley
|Luckbox expects the march toward wider EV adoption will continue nearly unabated -
A Trump Reelection Could Shake Up the Energy Industry
|If Donald Trump is reelected for a second term in November, the energy sector could experience a shake up due to renewed support for traditional fossil fuel companies and a…